In conclusion, hypertension and mutations in the ACE (rs4331) and ACE2 (rs2074192) genes can cause greater severity in COVID-19 patients; therefore, special attention and prompt treatment is needed in the clinical management of COVID-19 patients with hypertension. The gene discussed is ACE2; the disease is COVID-19.